JS

Jaijeet Singh Mor

Active Director Director DIN 10873698
DIN 10873698 First appointment Dec 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value •••• Premium profile

About Jaijeet Singh Mor

Data last updated:

Jaijeet Singh Mor is a Director at Strango Healthtech Private Limited (since 2024). Strango Healthtech Private Limited reported revenue of ₹9.9 Lakh (FY 2025).

DIN 10873698
Primary Designation Director
First Appointment 16 Dec 2024
Oldest Company Age 1 yrs
Largest company Strango Healthtech Private Limited · ₹9.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Strango Healthtech Private Limited U26600HR2024PTC126848
Director16 Dec 20242024₹9.9 Lakh (FY 2025)Active

Board colleagues of Jaijeet Singh Mor

Directorship timeline

Open interactive timeline →
Strango Healthtech Private Limited
Premium access

Shareholding and investment profile for Jaijeet Singh Mor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaijeet Singh Mor

Jaijeet Singh Mor currently holds 1 directorship: Strango Healthtech Private Limited (Director, since 16 Dec 2024, revenue ₹9.9 Lakh (FY 2025)).

Jaijeet Singh Mor was first appointed on 16 Dec 2024 as Director at Strango Healthtech Private Limited.

The current boards of Jaijeet Singh Mor's companies include Mohit (Strango Healthtech Private Limited), Ashish Yadav (Strango Healthtech Private Limited), Sunita Devi (Strango Healthtech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available